Trial · NCT01349972
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Complete Response Rate | Arm I (Alvocidib, Cytarabine, Mitoxantrone Hydrochloride) | 76 | participants | ||
| Complete Response Rate | Arm II (Cytarabine, Daunorubicin Hydrochloride) | 24 | participants | ||
| Incidence of Toxicities, Characterized by Number of Events by Treatment and Grade | Arm I (Alvocidib, Cytarabine, Mitoxantrone Hydrochloride) | 156 | Number of events | ||
| Incidence of Toxicities, Characterized by Number of Events by Treatment and Grade | Arm II (Cytarabine, Daunorubicin Hydrochloride) | 77 | Number of events | ||
| Disease-free Survival | Arm I (Alvocidib, Cytarabine, Mitoxantrone Hydrochloride) | 1.46 | Full Range 1.06 to 2.11 | years | |
| Disease-free Survival | Arm II (Cytarabine, Daunorubicin Hydrochloride) | 1.85 | Full Range 1.35 to 3.33 | years | |
| Overall Survival | Arm I (Alvocidib, Cytarabine, Mitoxantrone Hydrochloride) | 1.46 | 95% Confidence Interval 0.09 to 2.12 | years | |
| Overall Survival | Arm II (Cytarabine, Daunorubicin Hydrochloride) | 1.850 | 95% Confidence Interval 1.35 to 3.33 | years | |
| Number of Patients With Minimal Residual Disease | Arm I (Alvocidib, Cytarabine, Mitoxantrone Hydrochloride) | 26 | Participants | ||
| Number of Patients With Minimal Residual Disease | Arm II (Cytarabine, Daunorubicin Hydrochloride) | 24 | Participants | ||
| Progression-free Survival | Arm I (Alvocidib, Cytarabine, Mitoxantrone Hydrochloride) | 0.81 | 95% Confidence Interval 0.42 to 0.98 | years | |
| Progression-free Survival | Arm II (Cytarabine, Daunorubicin Hydrochloride) | 0.28 | 95% Confidence Interval 0.11 to 1.11 | years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01349972/results